Skip to main content
    P

    Passage Bio Inc (PASG)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $4.13
    -0.12 (-2.82%)

    Market Cap: $13.68M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Passage Bio Inc (PASG) Earnings: Report Dates and Results

    Updated Nov 10, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Passage Bio (PASG) is expected to report earnings on Mar 1, 2027. In the quarter ended Sep 30, 2026, Passage Bio reported EPS of -$1.47, above the -$2.43 estimate. It beat the EPS estimate in 4 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    54%(15/28)
    Avg Surprise
    +3.77%
    Streak
    1 Q

    Upcoming Estimates

    Reports Mar 1, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$2.60
    RangeN/A
    5 analysts
    Revenue Consensus
    N/A
    RangeN/A
    3 analysts
    Reports May 10, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$2.33
    Range-$4.06 - -$1.01
    6 analysts
    EPS Revisions
    0
    1
    30d
    EPS Estimate DriftChange to current
    90d ago-$2.02-15.2%
    60d ago-$2.03-14.6%
    30d ago-$1.93-20.8%
    7d ago-$2.08-11.9%
    Current-$2.33
    Revenue Consensus
    N/A
    RangeN/A
    1 analysts

    Next Report

    PASG has an expected report date of Mar 1, 2027.

    Earnings History

    Of the 28 quarters below that had an estimate, PASG beat 15, missed 10 and matched 3. The widest gap in the table came in the quarter ended Dec 31, 2025, when EPS landed 46.07% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$1.47-$2.43N/A+39.51%BeatN/A10 up, 0 downNov 10, 2026N/A
    Jun 30, 2026-$2.44-$2.20-$3.47 - -$2.20-10.91%MissN/A20 up, 1 downAug 10, 2026N/A
    Mar 31, 2026-$2.36-$3.06-$3.24 - -$2.84+22.89%BeatN/A51 up, 0 downMay 12, 2026N/A
    Dec 31, 2025-$4.09-$2.80-$2.98 - -$2.53-46.07%MissN/A51 up, 0 downMar 3, 2026N/A
    Sep 30, 2025-$2.44-$2.97-$3.13 - -$2.82+17.85%BeatN/A41 up, 0 downNov 10, 2025N/A
    Jun 30, 2025-$2.96-$4.15-$5.00 - -$3.20+28.67%BeatN/A40 up, 3 downAug 12, 2025N/A
    Mar 31, 2025-$5.00-$4.47-$4.60 - -$4.40-11.86%MissN/A31 up, 0 downMay 13, 2025N/A
    Dec 31, 2024-$0.20-$0.20-$0.24 - -$0.160.00%In lineN/A21 up, 0 downMar 4, 2025N/A
    Sep 30, 2024-$4.71-$4.67-$6.20 - -$2.60-0.86%MissN/A50 up, 0 downNov 13, 2024$99000
    Jun 30, 2024-$5.20-$6.20-$6.60 - -$5.80+16.13%BeatN/A50 up, 0 downAug 8, 2024$2000
    Mar 31, 2024-$6.00-$6.90-$8.20 - -$6.40+13.04%BeatN/A40 up, 0 downMay 14, 2024N/A
    Dec 31, 2023-$0.30-$0.40-$0.46 - -$0.35+25.00%BeatN/A50 up, 0 downMar 4, 2024$688000
    Sep 30, 2023-$7.93-$8.80-$10.40 - -$6.60+9.89%BeatN/A60 up, 0 downNov 13, 2023$148000
    Jun 30, 2023-$8.80-$9.55-$10.20 - -$9.00+7.85%BeatN/A70 up, 0 downAug 7, 2023$87000
    Mar 31, 2023-$12.60-$10.15-$11.40 - -$9.00-24.14%MissN/A80 up, 0 downMay 11, 2023N/A
    Dec 31, 2022-$0.49-$0.52-$0.73 - -$0.40+5.77%BeatN/A90 up, 0 downMar 6, 2023N/A
    Sep 30, 2022-$9.80-$15.44-$21.80 - -$13.40+36.53%BeatN/A90 up, 0 downNov 10, 2022$110000
    Jun 30, 2022-$14.60-$15.93N/A+8.35%BeatN/AN/A0 up, 0 downAug 4, 2022N/A
    Mar 31, 2022-$15.80-$18.38-$20.20 - -$15.40+14.04%BeatN/A90 up, 0 downMay 16, 2022N/A
    Dec 31, 2021-$0.95-$0.89-$1.15 - -$0.74-6.74%MissN/A90 up, 0 downMar 3, 2022N/A
    Sep 30, 2021-$17.40-$17.40-$20.40 - -$14.200.00%In lineN/A9N/ANov 4, 2021N/A
    Jun 30, 2021-$18.00-$15.15-$16.80 - -$13.20-18.81%MissN/A9N/AAug 5, 2021N/A
    Mar 31, 2021-$15.20-$14.14-$18.20 - -$12.00-7.50%MissN/A7N/AMay 5, 2021N/A
    Dec 31, 2020-$0.85-$0.70-$0.86 - -$0.63-21.43%MissN/A7N/AMar 3, 2021N/A
    Sep 30, 2020-$12.60-$13.35-$19.60 - -$12.00+5.62%BeatN/A4N/ANov 10, 2020N/A
    Jun 30, 2020-$12.00-$10.35-$13.00 - -$8.80-15.94%MissN/A4N/AAug 13, 2020N/A
    Mar 31, 2020-$7.76-$9.55-$9.60 - -$8.40+18.74%BeatN/A3N/AMay 11, 2020N/A
    Dec 31, 2019-$0.69-$0.69N/A0.00%In lineN/AN/AN/AFeb 28, 2020N/A
    Last 28 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$14.49, after -$16.11 the year before. It was -$0.69 for the year ended Dec 31, 2019, the oldest of the 7 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$14.49N/A
    Dec 31, 2024-$16.11N/A
    Dec 31, 2023-$29.63N/A
    Dec 31, 2022-$40.69N/A
    Dec 31, 2021-$51.55N/A
    Dec 31, 2020-$33.21N/A
    Dec 31, 2019-$0.69N/A

    Frequently Asked Questions About PASG

    When is Passage Bio's next earnings date?

    Passage Bio's next earnings report is expected for Mar 1, 2027.

    Did PASG beat earnings estimates last quarter?

    Yes. Passage Bio reported EPS of -$1.47 for the quarter ended Sep 30, 2026, above the -$2.43 estimate, a 39.51% surprise.

    What EPS do analysts expect from PASG next quarter?

    The consensus EPS estimate for Passage Bio for the quarter ending Dec 31, 2026 is -$2.60 from 5 analysts.

    How often does PASG beat earnings estimates?

    Passage Bio beat the EPS estimate in 4 of the last 8 quarters, with an average surprise of +5.01%.